details

Peer companies

;

Share Market News

Chemo Pharma Laboratories has informed that the Meeting of the Board of Directors of the Company will be held on January 23, 2017, to consider and approve the Un-Audited Financial Results for the quarter ended December 31, 2016, and to place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended December 31, 2016.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has submitted a copy of proceedings of 74th Annual General Meeting (AGM) of the Company held on August 30, 2016.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed about Standalone and Consolidated Auditors Report for the period ended March 31, 2016, and declaration regarding Audit Report with unmodified opinion.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed that the Register of Members & Share Transfer Books of the Company will remain closed from August 17, 2016 to August 30, 2016 for the purpose of Annual General Meeting (AGM) of the Company to be held on August 30, 2016.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed about Outcome of Board Meeting held on May 30, 2016.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed about Results of Postal Ballot.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed about Authorised KMPs to determine materiality of events/information.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has submitted a copy of Notice of Postal Ballot.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has submitted a copy of the limited review report for the period ended September 30, 2015.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has informed that as per the Company’s Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of Un-Audited Financial Results of the Company for the Quarter ended September 30, 2015 for all the Officers and Designated Employees (including Directors) of the Company from October 15, 2015 till October 28, 2015 i.e. 24 hours after the announcement of the Financial Results of the Company to the Stock Exchanges. Accordingly all Officers and Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of Trading Window.The above information is a part of company’s filings submitted to BSE.

Chemo Pharma Laboratories has submitted a copy of the Limited Review Report for the period ended June 30, 2015.The above information is a part of company’s filings submitted to BSE.